CRISPR Therapeutics AG CRSP
$ 46.2
-2.24%
Quarterly report 2024-Q3
added 11-05-2024
CRISPR Therapeutics AG EV/EBITDA Ratio 2011-2024 | CRSP
Annual EV/EBITDA Ratio CRISPR Therapeutics AG
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
13.1 | -30.4 | 37.1 | -7.01 | -23.2 | 1.46 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
37.1 | -30.4 | -1.51 |